Effectiveness of Isolating Clostridium Difficile Asymptomatic Carriers on the Incidence of Infections

NACompletedINTERVENTIONAL
Enrollment

4,138

Participants

Timeline

Start Date

August 25, 2017

Primary Completion Date

April 1, 2018

Study Completion Date

May 2, 2018

Conditions
Clostridium Difficile
Interventions
OTHER

Detection and isolation of C. difficile carriers

"Screening for C. difficile carriage will be conducted by performing a polymerase chain reaction (PCR) assay detecting the toxin B gene (tcdB) on a rectal swab. Screening will occur within 24 h of admission to the ward. To ensure compliance with the policy, automatic orders will be developed. The patient care nurse will perform the screenings. The results will be reported according to the standard institutional policy.~Isolation precautions for C. difficile carriers: healthcare workers will also follow a set of isolation precaution rules during the care of C. difficile carriers. C. difficile carriers will remain under isolation precaution as long as they remain carriers and on the intervention ward. Precautions would be discontinued upon discharge from the ward."

Trial Locations (5)

J4V 2H1

Hopital Charles Lemoyne, Greenfield Park

H3G 1A4

Montreal General Hospital, Montreal

H3S 1Y9

Jewish General Hospital, Montreal

H4A 3J1

McGill University Health Center, Montreal

G8Z 3R9

Centre Hospitalier Sainte-Marie, Trois-Rivières

Sponsors
All Listed Sponsors
collaborator

Becton, Dickinson and Company

INDUSTRY

collaborator

Sir Mortimer B. Davis - Jewish General Hospital

OTHER

lead

Yves Longtin

OTHER